相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low expression of γ-glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype
K. Kawakami et al.
BRITISH JOURNAL OF CANCER (2008)
Combination of O6-methylguanine-DNA methyltransferase and thymidylate synthase for the prediction of fluoropyrimidine efficacy
Takako Eguchi Nakajima et al.
EUROPEAN JOURNAL OF CANCER (2008)
Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracilresponsive subgroup?
Barry Iacopetta et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile
M. Ferracin et al.
JOURNAL OF PATHOLOGY (2008)
Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation
Sun Lee et al.
PATHOLOGY INTERNATIONAL (2008)
Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer
Shuji Ogino et al.
GUT (2007)
Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil - Based chemotherapy
Lanlan Shen et al.
CLINICAL CANCER RESEARCH (2007)
CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma
Shuji Ogino et al.
VIRCHOWS ARCHIV (2007)
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
J. R. Jass
HISTOPATHOLOGY (2007)
Suppression of DPYD expression in RKO Cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression
Xue Zhang et al.
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2007)
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Daniel J. Weisenberger et al.
NATURE GENETICS (2006)
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies
S. Ogino et al.
GUT (2006)
Microsatellite instability in colorectal cancer
K Söreide et al.
BRITISH JOURNAL OF SURGERY (2006)
Methylation of the DPYD promoter:: An alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients
HH Ezzeldin et al.
CLINICAL CANCER RESEARCH (2005)
Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries
AO Chan et al.
CLINICAL CANCER RESEARCH (2005)
MGMT promoter methylation and field defect in sporadic colorectal cancer
LL Shen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer
WS Samowitz et al.
GASTROENTEROLOGY (2005)
Differences in colorectal carcinoma stage and survival by race and ethnicity
C Chien et al.
CANCER (2005)
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers
WS Samowitz et al.
CANCER RESEARCH (2005)
Progressive methylation during the serrated neoplasia pathway of the colorectum
SM Dong et al.
MODERN PATHOLOGY (2005)
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum
T Kambara et al.
GUT (2004)
Opinion - CpG island methylator phenotype in cancer
JP Issa
NATURE REVIEWS CANCER (2004)
CpG island methylation in gastroenterologic neoplasia: A maturing field
A Rashid et al.
GASTROENTEROLOGY (2004)
Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells
T Noguchi et al.
CLINICAL CANCER RESEARCH (2004)
Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability
RL Ward et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
M van Rijnsoever et al.
GUT (2002)
Cancer survival among US whites and minorities - A SEER (Surveillance, Epidemiology, and End Results) program population-based study
LX Clegg et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability
N Hawkins et al.
GASTROENTEROLOGY (2002)
Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients
AS Soliman et al.
BRITISH JOURNAL OF CANCER (2001)
Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
T Watanabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Understanding the interaction between environmental exposures and molecular events in colorectal carcinogenesis
N Ishibe et al.
CANCER INVESTIGATION (2001)
Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors
B Van Triest et al.
ANNALS OF ONCOLOGY (2000)
分享论文
